| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |